The COVID-19 pandemic is an unrivaled scientific and global health challenge. As a company with a long legacy of research in infectious diseases, we have a responsibility to help.
We're rising to the challenge
We’ve been committed to trying to develop an effective response to the COVID-19 pandemic since it was first recognized. We know that success will require global collaboration among countries and companies and more.
Expanding manufacturing capacity and supply of COVID-19 medicines and vaccines
In March 2021, we announced an agreement with BARDA to adapt and make available a number of the company’s manufacturing facilities for production of COVID-19 vaccines and medicines. Additionally, we announced agreements with Johnson & Johnson to support manufacturing and supply of Johnson & Johnson’s SARS-CoV-2/COVID-19 vaccine.
Stories that inspire our work
Our work in the fight against COVID-19 reaches across all corners of our company, our personal lives and our communities, where many of our medically trained employees have volunteered their time.
Fighting for his family: One colleague’s battle with COVID-19
John Pratsinakis, director, global engineering solutions at our site in West Point, Pennsylvania, was home sick and running a fever for more than one week when his wife dropped him off at the hospital on a Thursday afternoon. He did not realize this would be the last time he would see her for weeks. Hours […]
A day in the life of a Merck physician and volunteer during COVID-19
Dr. Ali is continuing to fight on the front lines of the disease, despite the risks to himself and his loved ones
Businesses have a role to play in building vaccine trust. Here’s why
Employers are trusted messengers of credible information on vaccines